Transcriptional regulation of the hepatocyte growth factor gene by pyrrolidine dithiocarbamate
Abstract
Hepatocyte growth factor (HGF) mediates cancer cell invasion and metastasis. This study characterised the down-regulation of HGF expression by pyrrolidine dithiocarbamate (PDTC), which markedly reduced HGF mRNA expression and protein production in MRC-5 cells. Reporter gene studies revealed that PDTC inhibited HGF gene transcription and that the response element is located in the region −75 to +42
bp flanking the transcription initiation site. Electrophoretic mobility shift assay identified three specific protein complexes binding in this region, which were abrogated by exposure of cells to PDTC. PDTC deserves further investigation as a novel therapeutic agent for HGF-driven cancers.
Abbreviations: HGF, hepatocyte growth factor, PDTC, pyrrolidine dithiocarbamate, FCS, foetal calf serum, BS, bovine serum, PMA, phorbol 12-myristate 13-acetate, CAT, chloramphenicol acetyl transferase, EMSA, electrophoretic mobility shift assay, IL-1β, interleukin 1 beta, NAC, N-acetylcysteine
Keywords: Hepatocyte growth factor, Scatter factor, Pyrrolidine dithiocarbamate, Transcription factor, RNA stability
To access this article, please choose from the options below
PII: S0014-5793(08)00393-1
doi:10.1016/j.febslet.2008.04.055
© 2008 Federation of European Biochemical Societies. Published by Elsevier BV. All rights reserved.
